General Archive
-
News releasesLifeArc responds to the Government’s Spring Budget
LifeArc CEO Dr Melanie Lee responds to today’s Spring Budget.
-
News releasesThe Aisling Burnand Daphne Jackson Research Fellowship, sponsored by LifeArc
The Board at LifeArc announces today it is sponsoring five Daphne Jackson Fellowships.
-
News releases, Ventures fundingLifeArc Ventures invests in Maxion Therapeutics
Investment in Maxion Therapeutics to drive antibody development for previously untreatable ion channel and GPCR-driven diseases
-
News releases, Ventures fundingLifeArc Ventures – strong performance in 2022 & sustained investment in innovation
LifeArc Ventures, which is committed to investing in innovative early-stage life science companies, provides an update on its portfolio.
-
News releases£1 million awarded to develop cutting-edge therapies for motor neuron disease
London, 24 January 2023: Medical research charity LifeArc, the Motor Neurone Disease Association (MND Association) and the My Name’5 Doddie…
-
News releasesLifeArc portfolio company RQ Bio’s antibody enters clinical trials
The first of RQ Bio’s discovered monoclonal antibodies to prevent COVID-19 in vulnerable patients has entered clinical trials.
-
News releasesEvolving our science to solve complex healthcare challenges
Dave Powell on why LifeArc is evolving the way we do our science – and the difference we hope it…
-
News releasesLifeArc partners with EMBARC to improve healthcare for people living with bronchiectasis
Three-year partnership to improve healthcare for thousands of people across Europe living with bronchiectasis.
-
News releasesLifeArc announces £10m funding call for new chronic respiratory infection therapies
First major funding call announced as part of our £100m Chronic Respiratory Infection Translational Challenge
-
News releases
£100m programme to transform care for people living with chronic lung conditions
More than 300,000 people in the UK are living with bronchiectasis and more than 10,000 have been diagnosed with cystic…
-
News releases
LifeArc responds to the Government’s renewed pledge to increase R&D funding
LifeArc CEO Dr Melanie Lee welcomes the Government’s restatement of its commitment to increase R&D funding in today’s Autumn statement:…
-
News releasesLifeArc funds home monitoring trials for people with chronic respiratory conditions
Trials will examine the impact of home monitoring and machine learning decision support algorithms for people with CF and bronchiectasis.